PROTRACTED AMBULATORY INFUSION CANCER CHEMOTHERAPY BY THE WATKINS CHRONOMETRIC INFUSOR.
D000236:Adenoma; D000970:Antineoplastic Agents; D001943:Breast Neoplasms; D002296:Carcinosarcoma; D003110:Colonic Neoplasms; D003873:Dermatitis, Exfoliative; D004864:Equipment and Supplies; D005467:Floxuridine; D005472:Fluorouracil; D006801:Humans; D007260:Infusion Pumps; D007263:Infusions, Parenteral; D008175:Lung Neoplasms; D008228:Lymphoma, Non-Hodgkin; D008297:Male; D008545:Melanoma; D008727:Methotrexate; D016685:Mitomycin; D008937:Mitomycins; D010190:Pancreatic Neoplasms; D013274:Stomach Neoplasms; D013736:Testicular Neoplasms; D013964:Thyroid Neoplasms; D014062:Tongue Neoplasms; D014116:Toxicology
D000970:Antineoplastic Agents; D008937:Mitomycins; D005467:Floxuridine; D016685:Mitomycin; D005472:Fluorouracil; D008727:Methotrexate
ADENOMA; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOSARCOMA; COLONIC NEOPLASMS; DERMATITIS EXFOLIATIVA; EQUIPMENT AND SUPPLIES; FLUORODEOXYURIDINE; FLUOROURACIL; INFUSIONS, PARENTERAL; LUNG NEOPLASMS; LYMPHOSARCOMA; MELANOMA; METHOTREXATE; MITOMYCIN; PANCREATIC NEOPLASMS; STOMACH NEOPLASMS; TESTICULAR NEOPLASMS; THYROID NEOPLASMS; TONGUE NEOPLASMS; TOXICOLOGIC REPORT